GABAPENTIN
- Product NDC
- 51655-379
- 11-digit product format
- 516550379
- Labeler code
- 51655
- Product ID
- 51655-379_92dade1a-f9a7-83c9-e053-2995a90ab833
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- GABAPENTIN
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Northwind Pharmaceuticals
- Application
- ANDA090007
- Marketing category
- ANDA
- Marketing start
- 2018-06-20
- Marketing end
- 0000-00-00
- Substance
- GABAPENTIN
- Active strength
- 300 mg/1
- Pharmacologic classes
- Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 51655-379-25 | 2024-05-14 | C162847 | 48780-1 | ba0f9c33-13b3-a910-e053-dadaa90a0b85 | 92dade1a-f9ae-83c9-e053-2995a90ab833 |
| 51655-379-26 | 2024-05-14 | C162847 | 48780-1 | ba0f9c33-13b3-a910-e053-dadaa90a0b85 | 92dade1a-f9ae-83c9-e053-2995a90ab833 |
| 51655-379-52 | 2024-05-14 | C162847 | 48780-1 | ba0f9c33-13b3-a910-e053-dadaa90a0b85 | 92dade1a-f9ae-83c9-e053-2995a90ab833 |
| 51655-379-25 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-13b3-a910-e053-dadaa90a0b85 | 92dade1a-f9ae-83c9-e053-2995a90ab833 |
| 51655-379-26 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-13b3-a910-e053-dadaa90a0b85 | 92dade1a-f9ae-83c9-e053-2995a90ab833 |
| 51655-379-52 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-13b3-a910-e053-dadaa90a0b85 | 92dade1a-f9ae-83c9-e053-2995a90ab833 |